IP Library › Granted Patent US 11,649,325
Granted Patent B2
US 11,649,325 · App. 17/158,290 · Granted May 16, 2023

Actinically-crosslinkable polysiloxane-polyglycerol block copolymers and methods of making and use thereof

Inventors: Jong Gu Park (Singapore, SG); Yeong Shenq Chow (Singapore, SG); John Christopher Phelan (Singapore, SG)
Assignee: Clearlab SG Pte Ltd.
C08G77/46C08F293/00G02B1/043C08G2210/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,649,325
App. No.
17/158,290
Granted
May 16, 2023
Kind
B2
Abstract

Described herein are compositions comprising an actinically-crosslinkable polysiloxane-polyglycerol block copolymers, methods of making and use thereof, and devices comprising the compositions described herein. Disclosed herein are compositions comprising an actinically-crosslinkable polysiloxane-polyglycerol block copolymer derived from: a polysiloxane prepolymer comprising a polyglycerol side chain, the polyglycerol side chain comprising an ethylenically unsaturated group covalently linked thereto, wherein the ethylenically unsaturated group is actinically curable.

Claims (71)

1. A composition comprising an actinically-crosslinkable polysiloxane-polyglycerol block copolymer derived from: a polysiloxane prepolymer comprising a polyglycerol side chain, the polyglycerol side chain comprising an ethylenically unsaturated group covalently linked thereto, wherein the ethylenically unsaturated group is actinically curable.

2. The composition of claim 1 , wherein the polysiloxane prepolymer is linear or branched.

3. The composition of claim 1 , wherein the ethylenically unsaturated group is covalently linked to the polyglycerol side chain directly or wherein the ethylenically unsaturated group is covalently linked to the polyglycerol side chain through a linking group.

4. The composition of claim 1 , wherein the ethylenically unsaturated group comprises acryloyl, acrylamide, alkyl acrylamide, dialkyl acrylamide, methacryloyl, allyl, vinyl, styrenyl, or a combination thereof.

5. The composition of claim 1 , wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer is defined by Formula I:

wherein

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and J 1 are, independently, alkyl, cycloalkyl, aryl, alkylpolyethylene oxide, or polyglycerol, any of which is optionally substituted with halide, hydroxy, thiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , azide, or a combination thereof;

Q 1 and Q 2 are independently H, OH, amino, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl, any of which is optionally substituted with epoxy, hydroxy, thiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , azide, or a combination thereof;

R x and R y are independently H, OH, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl;

Cure Group comprises the ethylenically unsaturated group;

a, c, d, e, f, g, h, i, j, and k are, independently, an integer from 0 to 10,000;

with the proviso that:

at least one of e, g, h, and j is not 0, and

at least one of d, f, i, and k is not 0; and

b is an integer from 1 to 10,000.

6. The composition of claim 5 , wherein:

R 1 -R 11 and J 1 are, independently, C 1 -C 18 alkyl, C 3 -C 18 cycloalkyl, C 3 -C 20 aryl, alkylpolyethylene oxide, or polyglycerol, any of which is optionally substituted; and

Q 1 and Q 2 are independently C 1 -C 18 alkyl, C 3 -C 20 aryl, C 1 -C 18 perfluoroalkyl, C 1 -C 18 alkanol, C 1 -C 18 alkylthiol, C 1 -C 18 alkylamine, C 1 -C 18 dialkylamine, any of which is optionally substituted.

7. The composition of claim 5 , wherein the Cure Group is selected from the group consisting of:

wherein

R a is H, alkyl, or cycloalkyl, either of which is optionally substituted with halide, hydroxy, alkylthiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , or a combination thereof; and

R x and R y are independently H, OH, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl.

8. The composition of claim 1 , wherein the polysiloxane prepolymer comprises polydimethylsiloxane.

9. The composition of claim 1 , wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer is defined by Formula IX:

wherein

a, c, e, f, i, j and k are, independently, an integer from 0 to 10,000;

with the proviso that:

at least one of e and j is not 0, and

at least one of f, i, and k is not 0; and

b is an integer from 1 to 10,000.

10. The composition of claim 1 , wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer is defined by Formula X:

wherein

a, c, e, f, i, j and k are, independently, an integer from 0 to 10,000;

with the proviso that:

at least one of e and j is not 0, and

at least one of f, i, and k is not 0; and

b is an integer from 1 to 10,000.

11. The composition of claim 1 , wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer is defined by Formula XI:

wherein

a, c, e, f, i, j and k are, independently, an integer from 0 to 10,000;

with the proviso that:

at least one of e and j is not 0, and

at least one of f, i, and k is not 0; and

b is an integer from 1 to 10,000.

12. The composition of claim 1 , wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer comprises a methacrylated polydimethylsiloxane-polyglycerol block copolymer; a chain extended actinically-crosslinkable polysiloxane-polyglycerol block copolymer; or a combination thereof.

13. The composition of claim 1 , wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer comprises a chain extended actinically-crosslinkable polysiloxane-polyglycerol block copolymer and the chain extended actinically-crosslinkable polysiloxane-polyglycerol block copolymer is defined by Formula XII:

wherein

R 1 , R 1′ , R 2 , R 2′ , R 3 , R 3′ , R 4 , R 4′ , R 5 , R 5′ , R 6 , R 6′ , R 7 , R 7′ , R 8 , R 8′ , R 9 , R 9′ , R 10 , R 10′ , R 11 , R 11′ , J 1 , and J 1′ are, independently, alkyl, cycloalkyl, aryl, alkylpolyethylene oxide, or polyglycerol, any of which is optionally substituted with halide, hydroxy, thiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , azide, or a combination thereof;

Q 1 , Q 1′ , Q 2 , and Q 2′ are independently H, OH, amino, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl, any of which is optionally substituted with epoxy, hydroxy, thiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , azide, or a combination thereof;

R x and R y are independently H, OH, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl;

Cure Group and Cure Group′ independently comprise an ethylenically unsaturated group;

Z is a chain extension group;

a, a′, c, c′, d, d′, e, e′, f, f′, g, g′, h, h′, j, j′, k, and k′ are, independently, an integer from 0 to 10,000,

with the proviso that:

at least one of e, g, h, and j is not 0,

at least one of e′, g′, h′, and j′ is not 0,

at least one of d, f, i, and k is not 0, and

at least one of d′, f′, i′, and k′ is not 0; and

b and b′ are independently an integer from 1 to 10,000.

14. The composition of claim 13 , wherein:

R 1 -R 11 , R 1′ -R 11′ , J 1 , and J 1′ are, independently, C 1 -C 18 alkyl, C 3 -C 18 cycloalkyl, C 3 -C 20 aryl, alkylpolyethylene oxide, or polyglycerol, any of which is optionally substituted; and

Q 1 , Q 1′ , Q 2 , and Q 2′ are independently H, OH, aryl, epoxide, alkanol, alkylthio, alkenylthio, arylthio, amine, alkylamine, dialkylamine, (meth)acrylate, (meth)acrylamide, dialkyl (meth)acrylamide, vinyl, ketone, aldehyde, carboxylic acid, anhydride, or azide, any of which is optionally substituted.

15. The composition of claim 13 , wherein Cure Group and Cure Group′ are independently selected from the group consisting of:

wherein

R a is H, alkyl, or cycloalkyl, either of which is optionally substituted with halide, hydroxy, alkylthiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , or a combination thereof; and

R x and R y are independently H, OH, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl.

16. A silicone hydrogel composition comprising the composition of claim 1 crosslinked with a crosslinker.

17. An interpenetrating polymer network comprising the composition of claim 1 crosslinked with a crosslinker in the presence of an initiator, a hydrophilic monomer, a hydrophobic monomer, an amphiphilic monomer, a zwitterionic monomer, a UV-blocker, a blue light blocker, an antimicrobial monomer, a dye, a pigment, a solvent, or a combination thereof.

18. A method of use of the composition of claim 1 in a medical device, in an ophthalmic device, as a coating for a medical device, as a wound dressing, or a combination thereof.

19. A contact lens comprising the composition of claim 1 , wherein the contact lens comprises a soft, hydrophilic contact lens.

20. The contact lens of claim 19 , wherein the contact lens exhibits hydrophilic surfaces without a post-curing surface treatment.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2021
From: PARK, JONG GU; CHOW, YEONG SHENQ; PHELAN, JOHN CHRISTOPHER
To: CLEARLAB SG PTE LTD.
Reel/Frame 056597/0241 →
Continuity (2)
Provisional Application 62966233 · Jan 27, 2020
Related Publication 20210246270A1 · Aug 12, 2021